Title of article
Cyclooxygenase-2 inhibitors dilemma in cardiovascular medicine: Are all family members bad players?
Author/Authors
Turgay Celik، نويسنده , , Atila Iyisoy، نويسنده , , Hurkan Kursaklioglu، نويسنده , , U. Cagdas Yuksel، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2007
Pages
2
From page
259
To page
260
Abstract
Cyclooxygenase-2 (COX-2) inhibitors dilemna in cardiovascular medicine has not been resolved yet. The cardiovascular safety of selective COX-2 inhibitors other than rofecoxib is uncertain. Given the ongoing controversy surrounding the use of COX-2 inhibitors, futher clinical studies with different types of drugs are required to establish safety and therapeutic benefit in patients with coronary artery disease.
Keywords
Cardiovascular medicine , coronary artery disease , Cyclooxygenase-2 Inhibitors
Journal title
International Journal of Cardiology
Serial Year
2007
Journal title
International Journal of Cardiology
Record number
814840
Link To Document